PG

Procter & Gamble Price

Closed
PG
$146,93
+$3,82(+%2,66)

*Data last updated: 2026-04-19 11:31 (UTC+8)

As of 2026-04-19 11:31, Procter & Gamble (PG) is priced at $146,93, with a total market cap of $343,33B, a P/E ratio of 24,47, and a dividend yield of %2,87. Today, the stock price fluctuated between $143,40 and $147,59. The current price is %2,46 above the day's low and %0,44 below the day's high, with a trading volume of 10,86M. Over the past 52 weeks, PG has traded between $137,62 to $170,99, and the current price is -%14,07 away from the 52-week high.

PG Key Stats

Yesterday's Close$143,11
Market Cap$343,33B
Volume10,86M
P/E Ratio24,47
Dividend Yield (TTM)%2,87
Dividend Amount$1,05
Diluted EPS (TTM)6,79
Net Income (FY)$15,97B
Revenue (FY)$84,28B
Earnings Date2026-04-24
EPS Estimate1,56
Revenue Estimate$20,55B
Shares Outstanding2,39B
Beta (1Y)0.403
Ex-Dividend Date2026-01-23
Dividend Payment Date2026-02-17

About PG

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands. The Grooming segment provides shave care products and appliances under the Braun, Gillette, and Venus brand names. The Health Care segment offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brand names; and gastrointestinal, rapid diagnostics, respiratory, vitamins/minerals/supplements, pain relief, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands. The Fabric & Home Care segment provides fabric enhancers, laundry additives, and laundry detergents under the Ariel, Downy, Gain, and Tide brands; and air care, dish care, P&G professional, and surface care products under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. The Baby, Feminine & Family Care segment offers baby wipes, taped diapers, and pants under the Luvs and Pampers brands; adult incontinence and feminine care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands. The company sells its products primarily through mass merchandisers, e-commerce, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores, high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.
SectorConsumer Defensive
IndustryHousehold & Personal Products
CEOShailesh G. Jejurikar
HeadquartersCincinnati,OH,US
Official Websitehttp://us.pg.com
Employees (FY)109,00K
Average Revenue (1Y)$773,24K
Net Income per Employee$146,55K

Procter & Gamble (PG) FAQ

What's the stock price of Procter & Gamble (PG) today?

x
Procter & Gamble (PG) is currently trading at $146,93, with a 24h change of +%2,66. The 52-week trading range is $137,62–$170,99.

What are the 52-week high and low prices for Procter & Gamble (PG)?

x

What is the price-to-earnings (P/E) ratio of Procter & Gamble (PG)? What does it indicate?

x

What is the market cap of Procter & Gamble (PG)?

x

What is the most recent quarterly earnings per share (EPS) for Procter & Gamble (PG)?

x

Should you buy or sell Procter & Gamble (PG) now?

x

What factors can affect the stock price of Procter & Gamble (PG)?

x

How to buy Procter & Gamble (PG) stock?

x

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.

Hot Posts About Procter & Gamble (PG)

BoredApeResistance

BoredApeResistance

04-16 12:02
So I've been tracking this uranium play for a while now, and honestly the setup looks pretty compelling right now. Everyone's focused on AI, but what's flying under the radar is the energy crisis that's about to hit us. Let me break down why uranium stocks might be one of the best moves for patient investors. First, the supply side is getting squeezed hard. Russia's uranium ban kicked in August last year, and Kazakhstan just tightened extraction taxes. Meanwhile, electricity demand is about to explode. We're talking 20% growth by 2030 just from AI data centers alone. According to the numbers, those data centers alone will pull 323 terawatt hours of electricity annually - that's seven times New York City's entire current consumption. By 2030, data centers are projected to eat up 8% of all U.S. electricity. That's not small. That's structural demand that nuclear energy has to fill. Here's where it gets interesting though - uranium supply can't keep pace. The deficit projections are wild. We're looking at potential 240-million-pound shortfalls by 2040, which means the world needs to build over 5 new major uranium mines in the next 20 years. Current mine supply has never been more fragile, which is exactly why uranium stocks are positioned for serious upside. Let me walk through some of the best uranium stocks worth watching. Cameco (CCJ) is the obvious anchor play here. Bank of America added it to their US 1 List, Goldman Sachs raised their target to $56, and RBC Capital is actively buying on weakness. Their recent earnings were soft - 13 cents versus 26 cents expected - but the CEO is pretty clear that market tightness and mine depletion will keep prices elevated. NexGen Energy (NXE) is another one that caught my attention. If their Rook 1 project gets Canadian approval, we could be looking at one of the world's largest uranium mines. What's compelling is their demand forecast - they're modeling 127% uranium demand growth by 2030, jumping to 200% by 2040. That's the kind of structural shift that makes long-term uranium stocks attractive. Energy Fuels (UUUU) is trading oversold at $5.60. The insider buying back in May was telling - about 11 insiders loaded up, including the CEO and several directors. The Russian ban opened up $2.7 billion in authorized funding for domestic LEU production, which directly benefits companies like this. Denison Mines (DNN) broke below key moving averages recently but the technicals are screaming oversold. Roth MKM just initiated coverage with a buy and $2.60 target. Their McLean Lake mill can process 24 million pounds annually, which gives them serious strategic value in the medium term. Paladin Energy (PALAF) is trading at $7.38 and also showing oversold signals. The acquisition of Fission Uranium would make them the third-largest uranium producer globally, churning out 10% of world supply. Morgan Stanley has a $11.66 target on this one. If you want broader exposure without picking individual stocks, there are a couple of clean uranium ETF plays. The Sprott Uranium Miners ETF (URNM) is a pure-play junior mining fund with a 0.80% expense ratio. It holds most of these names - Paladin, Uranium Energy, Denison, Energy Fuels. The VanEck Uranium and Nuclear Energy ETF (NLR) is broader at 0.64% expense ratio, mixing in nuclear utilities like Constellation Energy and PG&E alongside the miners. Look, the thesis here is straightforward. Demand for uranium is about to spike due to AI infrastructure build-out. Supply can't match that demand for years. You've got a structural imbalance, which historically is how you get explosive moves in commodity plays. The best uranium stocks are technically oversold right now, which means the risk-reward is tilted in your favor if you're thinking long-term. This isn't a quick flip - this is the kind of position you hold while the AI energy story plays out over the next several years.
0
0
0
0
CodeAuditQueen

CodeAuditQueen

04-07 17:08
I’ve been paying close attention to the uranium energy sector lately, and the opportunities really do seem worth taking seriously. The main reasons are actually pretty clear: on the one hand, the supply side is tightening— the Russian uranium ban takes effect in August, and Kazakhstan has also increased extraction taxes— which directly limits supply growth. On the other hand, the electricity demand of AI data centers is growing explosively, which could be even more exaggerated than many people imagine. I looked into data from Wells Fargo: just AI data centers alone will need an additional 323 terawatt-hours of electricity by 2030, which is more than 6 times New York City’s total annual consumption. Goldman Sachs is even more aggressive, predicting that data centers will account for 8% of total U.S. electricity consumption. With demand growing at this scale, nuclear energy is definitely something you can’t avoid, so “uranium stocks to buy” now does seem to make sense. In terms of specific targets, Cameco (CCJ) was recently added to Bank of America’s US1 list, and Goldman Sachs has also raised its target price to $56. RBC Capital recommends buying on pullbacks. Although the most recent quarter’s performance has been a bit disappointing (adjusted EPS of 13 cents, below the expected 26 cents), management put it very plainly: tight supply, mine depletion, and underinvestment will continue to support uranium prices. For NexGen Energy (NXE), if the Rook 1 project receives Canadian approval, it could become one of the world’s largest uranium mines. Their numbers are even more aggressive: they expect uranium demand to grow by 127% by 2030 and 200% by 2040. Moreover, they estimate a potential supply gap of 240 million pounds in 2040— and only five Rook I-level projects would be needed to fill such a gap. If you want a more diversified exposure, Energy Fuels (UUUU), Denison Mines (DNN), and Paladin Energy (PALAF) are all good “uranium stocks to buy” options. UUUU recently saw 11 insiders start building positions in early May, including the CEO and a vice president— this is usually a good sign. DNN was rated a buy by Roth MKM with a target price of $2.60; they believe the company could become a low-cost uranium producer. PALAF was rated a buy by six analysts with an average target price of $10.71, and after acquiring Fission Uranium, they will become the world’s third-largest uranium producer. For an even broader exposure, Sprott Uranium Miners ETF (URNM) and VanEck Uranium and Nuclear Energy ETF (NLR) are also good tools. URNM has a fee of 0.80% and tracks small- and mid-cap uranium mining companies; at a current price of a bit over $22, URNJ looks very cheap. NLR has a lower fee of 0.64%. Its holdings include Constellation Energy, Cameco, PG&E, and more— making it another way to invest in “uranium stocks to buy.” Overall, the logic behind this sector is solid: the supply side is tightening, the demand side is exploding, and this trend could last for many years. If you enter now, it’s also not impossible to leave some assets for future generations.
0
0
0
0
RunWithRugs

RunWithRugs

03-18 08:10
(MENAFN- IANS) New Delhi, March 16 (IANS) PhonePe on Monday announced that it has temporarily deferred its public market listing process due to the current geopolitical conflicts and market volatility and will resume the listing process once there is some stability in global capital markets. Sameer Nigam, PhonePe's CEO said "We sincerely hope for a swift return to peace in all the affected regions. We remain committed to a public listing in India." As of September 30, 2025, PhonePe has over 65 crore registered users and a digital payments acceptance network spread across over 4.7 crore merchants. Meanwhile, in January this year, PhonePe Payment Gateway (PhonePe PG) announced the launch of 'PhonePe PG Bolt' for Visa and Mastercard Credit and Debit card transactions. The solution utilises device tokenisation to provide a secure and efficient in-app checkout experience for PhonePe platform users and merchant partners, according to its official statement. This feature allows users to tokenise their Mastercard and Visa cards once on the PhonePe app, enabling them to use their saved cards across any merchant integrated with PhonePe PG instead of having to tokenise their card separately with every merchant. By replacing sensitive card details with secure tokens, the system removes the requirement for CVV entry during subsequent transactions carried out on the same device. This architecture reduces the number of steps in the payment journey, maintaining the user within the merchant's app environment throughout the process and eliminating traditional redirects to external pages. "The launch of PhonePe PG Bolt feature for Visa and Mastercard is a significant step in our journey to simplify digital payments for millions of Indians. By leveraging device tokenisation, we will enable users and merchants to move away from the traditional, cumbersome checkout process to a secure, one-click payment experience,” said Yuvraj Singh Shekhawat, Chief Business Officer of Merchant Business at PhonePe Limited. “This not only enhances user convenience but also empowers our merchant partners to maximize their growth through industry-best success rates and reduced drop-offs," Shekhawat added. MENAFN16032026000231011071ID1110865323
0
0
0
0